par Galmarini, Carlos M;Martin, Maud ;Bouchet, Benjamin Pierre;Guillen-Navarro, María José;Martínez-Diez, Marta;Martinez-Leal, Juan Fernando;Akhmanova, Anna;Aviles, Pablo
Référence BMC cancer, 18, 1, page (164)
Publication Publié, 2018-05-01
Référence BMC cancer, 18, 1, page (164)
Publication Publié, 2018-05-01
Article révisé par les pairs
Titre: |
|
Auteur: | Galmarini, Carlos M; Martin, Maud; Bouchet, Benjamin Pierre; Guillen-Navarro, María José; Martínez-Diez, Marta; Martinez-Leal, Juan Fernando; Akhmanova, Anna; Aviles, Pablo |
Informations sur la publication: | BMC cancer, 18, 1, page (164) |
Statut de publication: | Publié, 2018-05-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Angiogenesis inhibitors |
Cancer treatment | |
Endothelial cells | |
Plocabulin (PM060184) | |
Tubulin inhibitors | |
Vascular-disrupting agents | |
MeSH keywords: | Animals |
Cell Line | |
Cell Line, Tumor | |
Cell Movement -- drug effects | |
Female | |
Human Umbilical Vein Endothelial Cells -- drug effects -- metabolism -- physiology | |
Humans | |
Mice, Nude | |
Microtubules -- drug effects -- metabolism | |
Neoplasms -- blood supply -- drug therapy -- pathology | |
Neovascularization, Pathologic -- prevention & control | |
Neovascularization, Physiologic -- drug effects | |
Polyketides -- metabolism -- pharmacology | |
Protein Binding | |
Pyrones -- metabolism -- pharmacology | |
Tubulin -- metabolism | |
Tumor Burden -- drug effects | |
Xenograft Model Antitumor Assays | |
Langue: | Anglais |
Identificateurs: | urn:issn:1471-2407 |
info:doi/10.1186/s12885-018-4086-2 | |
info:pii/10.1186/s12885-018-4086-2 | |
info:pmid/29415678 | |
PMC5803861 |